Clobazam: a review of its pharmacological properties and therapeutic use in anxiety

Drugs
R N BrogdenG S Avery

Abstract

Clobazam1 is a 1,5-benzodiazepine with antianxiety and anticonvulsant properties, advocated for the treatment of primary anxiety and that associated with organic or functional disorders. Clobazam itself has a half-life of 18 hours, but that of the principal metabolite, N-desmethylclobazam, is about 50 hours. Although the metabolite is pharmacologically less active than the parent drug, steady-state plasma concentrations of the metabolite are 8 times higher than those of the unchanged drug. Therapeutic trials indicate that the antianxiety effect of clobazam 30 to 80 mg daily is comparable with that of half its dose of diazepam. Clobazam has minimal muscle relaxant and hypnotic activity. Although subjective drowsiness has occurred with similar frequency with clobazam and diazepam in some studies, clobazam causes less objectively measured sedation or psychomotor impairment in experimental studies. Results of studies of vigilance and psychomotor performance during therapeutic use in patients are less conclusive, but clobazam may be useful in anxious patients who experience such impairment with other benzodiazepines.

Citations

Feb 16, 1984·The New England Journal of Medicine
Jun 1, 1981·British Journal of Clinical Pharmacology·G TedeschiA Baruzzi
Nov 1, 1981·British Journal of Clinical Pharmacology·D J GreenblattR I Shader
Jan 1, 1982·European Journal of Clinical Pharmacology·C ArnauC Vallvé
Jun 1, 1994·Pharmacology & Toxicology·S Monjanel-MouterdeJ P Cano
Jan 1, 1984·European Journal of Clinical Pharmacology·H R OchsB Verburg-Ochs
Jun 23, 2005·Current Medical Research and Opinion·Eric Michael Kaplan, Robert L DuPont
Oct 12, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Myung Joo KangJaehwi Lee
Jul 30, 2010·Molecular Diversity·Ahmad ShaabaniAfshin Sarvary
Apr 29, 2015·CNS Neuroscience & Therapeutics·Angela C Gauthier, Richard H Mattson
Jun 18, 1983·British Medical Journal·N Hockings, B R Ballinger
Nov 17, 2001·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·W WielingM Linzer
Mar 28, 2012·Expert Review of Neurotherapeutics·Hussam Seif-Eddeine, Yu-Tze Ng
Oct 1, 1982·European Journal of Clinical Pharmacology·A C ParrottP D Stonier
Jun 17, 2008·Journal of Combinatorial Chemistry·Ahmad ShaabaniHamid Mofakham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Journal of Clinical Pharmacology
G W Hanks
Clinical and Experimental Neurology
C KilpatrickR Moulds
Actas luso-españolas de neurología, psiquiatría y ciencias afines
M Pallarés
The Journal of Pharmacy and Pharmacology
S CacciaS Garattini
© 2021 Meta ULC. All rights reserved